Add like
Add dislike
Add to saved papers

A visible-light-driven heterojuncted composite WO 3 /Bi 12 O 17 Cl 2 : Synthesis, characterization, and improved photocatalytic performance.

Novel visible-light-driven WO3 /Bi12 O17 Cl2 heterojuncted photocatalysts with different mass ratios were successfully fabricated by a facile hydrothermal process and were characterized by XRD, UV-Vis DRS, SEM, TEM, HRTEM, XPS, BET, Raman, PL, and ESR techniques. The original morphology of Bi12 O17 Cl2 was maintained after the addition of WO3 nanoparticles and the specific surface area values of WBx composites were obviously enlarged. The intimate contact of both components in HRTEM confirmed the generation of smooth phase interface. These as-prepared samples were subjected to the photocatalytic degradation of dye rhodamine B (RhB) and tetracycline hydrochloride (TC) under visible light irradiation (λ≥420nm). Under identical conditions, WBx composites showed greatly enhanced photocatalytic performance in comparison to bare WO3 and Bi12 O17 Cl2 . Especially, the sample WB0.5 exhibited the highest photocatalytic removal outcome over RhB among all tested candidates and owned an apparent rate constant about 73.7, 7.1, 15.8 times of those pure WO3 , Bi12 O17 Cl2 , and N-doped TiO2 , respectively. The enhancement of photocatalytic capability of composites mainly attributed to the suitable morphology, enlarged specific surface areas, strengthened optical property, and favorable well-aligned straddling band-structures. Active species entrapping experiments confirmed holes and superoxide radicals as major oxidative species, by which, a possible photocatalytic mechanism was primarily proposed.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app